The European Pharmacopoeia is published by the European Directorate for the Quality of Medicines & HealthCare (EDQM) of the Council of Europe in Strasbourg. The publication contains standardised specifications defining the quality of pharmaceutical preparations, their constituents and containers.
The Finnish Medicines Agency Fimea is the Finnish national authority in pharmacopoeia matters.
The European Pharmacopoeia can be ordered from:
- EDQM Online Store
- EDQM Publications, (European Pharmacopoeia), 7 allée Kastner, CS 30026, F-67081 Strasbourg, France; fax +33 3 88 41 27 71; e-mail: email@example.com
The fourth supplement of the ninth edition (Supplement 9.4) of the European Pharmacopoeia will be implemented on April 1, 2018.
Due to the public health risk associated with histamine contamination, further requirements related to the quality of raw materials have been added to the Raw materials section of the monograph on Products of fermentation (1468). The revised monograph will be implemented on 1 April 2018. The pdf version of the text is available on the EDQM website.
The National pharmacopoeia documents have been updated according to the Supplement 9.4.
All approved standard terms and their definitions and translations can be found in the Standard Terms database maintained by EDQM (EDQM- Standard Terms database).The database requires a registration, but is open and free for all users. The registration takes place on the EDQM website (EDQM – Standard Terms, registration).